James Hardie Industries
JHX · ASX
About JHX
- Employees
- 7,500
- Headquarters
- DUBLIN, Dublin
- Listed
- Oct 15, 2001
- Sector
- Materials
- Industry
- Construction Materials
- Website
- ir.jameshardie.com.au
JHX key statistics
- Market cap
- 21.96B
- Price-earnings ratio
- 0.00
- Dividend yield
- 2.07%
- Average volume
- 7.88M
- Volume
- 5.59M
- Open price
- $26.46
- High today
- $26.66
- Low today
- $25.93
- 52 Week high
- $31.43
- 52 Week low
- $16.46
James Hardie Industries (JHX) at a glance
As of Oct 23, 2026, James Hardie Industries (JHX) shares are priced at $26.15, giving the company a market cap of 21.96B, a price-to-earnings ratio of 0.00 and a dividend yield of 2.07%.
Today the stock has traded between $25.93 and $26.66. The current price is 0.8% above the day's low and 1.9% below its high.
Volume so far is 5.59M shares, below the average of 7.88M shares a day.
Over the past year James Hardie Industries has ranged from $16.46 to $31.43, and now sits 65% of the way up that range.
James Hardie Industries met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q1 FY27 it reported $0.36 per share against an estimate of $0.326.
The average analyst price target is $32.11, 22.8% above the current price, from 9 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy88.9%
- Hold11.1%
- Sell0.0%
- Low
- $27.90
- Now
- $26.15
- High
- $37.10
JHX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 5.6% on average.
- Q2 FY25: reported $0.36 per share against an estimate of $0.3386
- Q3 FY25: reported $0.36 per share against an estimate of $0.3521
- Q4 FY25: reported $0.36 per share against an estimate of $0.3674
- Q1 FY26: reported $0.29 per share against an estimate of $0.3367
- Q2 FY26: reported $0.26 per share against an estimate of $0.2517
- Q3 FY26: reported $0.24 per share against an estimate of $0.2452
- Q4 FY26: reported $0.30 per share against an estimate of $0.3109
- Q1 FY27: reported $0.36 per share against an estimate of $0.326
JHX news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
James Hardie Launches “The Home of Resilient Beauty™,” Uniting Its Portfolio of Brands to Advance the Future of Resilient Building Products
- Press releaseBusiness Wire
James Hardie Announces Appointment of New Non-Executive Director
- Press releasePRNewswire
American Savings Bank Raises $129 Million in IPO: NYSE Content Update
- Press releaseBusiness Wire
James Hardie Hosts 2026 Investor Day, Outlines Path to Long-term Value Creation
- Press releaseBusiness Wire
James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million
- Press releaseBusiness Wire
James Hardie Reports First Quarter FY27 Results; Raises FY27 Outlook
- Press releaseBusiness Wire
James Hardie to Expand Regional Distribution Partnerships
Similar companies
Companies in the same industry as James Hardie Industries
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.